Citigroup Reiterates “€83.00” Price Target for Fresenius SE & Co KGaA (FRE)

Fresenius SE & Co KGaA (FRA:FRE) received a €83.00 ($102.47) price objective from Citigroup in a research report issued to clients and investors on Monday. The brokerage presently has a “buy” rating on the stock. Citigroup’s price objective would suggest a potential upside of 31.87% from the stock’s current price.

A number of other research analysts also recently commented on FRE. Goldman Sachs Group set a €74.50 ($91.98) price objective on shares of Fresenius SE & Co KGaA and gave the company a “neutral” rating in a research report on Tuesday, January 30th. Berenberg Bank set a €89.10 ($110.00) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Friday, February 2nd. Barclays set a €81.00 ($100.00) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Friday, February 2nd. Warburg Research set a €80.00 ($98.77) target price on shares of Fresenius SE & Co KGaA and gave the company a “buy” rating in a research note on Thursday. Finally, UBS Group set a €59.00 ($72.84) target price on shares of Fresenius SE & Co KGaA and gave the company a “sell” rating in a research note on Friday, January 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of €78.80 ($97.28).

Fresenius SE & Co KGaA (FRA FRE) opened at €62.94 ($77.70) on Monday. Fresenius SE & Co KGaA has a 1 year low of €60.16 ($74.27) and a 1 year high of €80.00 ($98.77). The company has a market cap of $33,990.00 and a P/E ratio of 20.04.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/12/citigroup-reiterates-83-00-price-target-for-fresenius-se-co-kgaa-fre.html.

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply